Prospective evaluation of ustekinumab(UST)- effects in patients with ulcerative colitis
Not Applicable
Recruiting
- Conditions
- ulcerative colitis
- Registration Number
- JPRN-UMIN000039946
- Lead Sponsor
- Saitama Medical Ctnter, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients without informed consent 2. Patients determined to be inappropriate for this study by doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Persistence of ustekinumab at week 56
- Secondary Outcome Measures
Name Time Method